Type to search

Marina Udier

Share
Marina Udier
CEO
Nouscom

Marina Udier

Executive with business and leadership experience in multinational, Big Pharma (Novartis), and in private VC backed startup (Nouscom, funded by 5AM, Versant, EQT, Abingworth). Independent Board Director of a NASDAQ listed company.

KEY SKILLS AND ACHIEVEMENTS:
• Lead a clinical stage IO biotech (50 FTEs) through the first IND submission, regulatory clearance, and initiation of the First in Human clinical trial (multi-site US trial, in Ph2). Oversaw CTA submission of the second clinical candidate in Europe
• Business development and financing: executed €42M private equity financing for an oncology biotech developing cancer vaccine. Executed two licensing and manufacturing agreements with a Big Pharma (Fortune 500) and brought first collaboration product to IND approval.
• Operational leadership: Negotiated partnership, managed alliance, lead development of a Companion Diagnostics required for selection of patients for treatment with Rydapt™ (new AML drug, approved in 2017).
• People leadership: Recruited a predominantly female executive team including CMO, VP Finance, Technical Director, CBO, and HR Head; lead a company with 80%+ female employees. Experience leading virtual, global, multi-cultural teams in US, EU, and Asia.

Posts Featuring Marina Udier


Warning: Illegal string offset 'ID' in /home/customer/www/pharmtechfocus.com/public_html/wp-content/themes/magplus-child/single-people.php on line 101

Warning: Illegal string offset 'ID' in /home/customer/www/pharmtechfocus.com/public_html/wp-content/themes/magplus-child/single-people.php on line 101

Warning: Illegal string offset 'ID' in /home/customer/www/pharmtechfocus.com/public_html/wp-content/themes/magplus-child/single-people.php on line 101

Warning: Illegal string offset 'ID' in /home/customer/www/pharmtechfocus.com/public_html/wp-content/themes/magplus-child/single-people.php on line 101

Warning: Illegal string offset 'ID' in /home/customer/www/pharmtechfocus.com/public_html/wp-content/themes/magplus-child/single-people.php on line 101

Warning: Illegal string offset 'ID' in /home/customer/www/pharmtechfocus.com/public_html/wp-content/themes/magplus-child/single-people.php on line 101

Warning: Illegal string offset 'ID' in /home/customer/www/pharmtechfocus.com/public_html/wp-content/themes/magplus-child/single-people.php on line 101

Warning: Illegal string offset 'ID' in /home/customer/www/pharmtechfocus.com/public_html/wp-content/themes/magplus-child/single-people.php on line 101

Warning: addcslashes() expects parameter 1 to be string, array given in /home/customer/www/pharmtechfocus.com/public_html/wp-includes/class-wpdb.php on line 1562
Nouscom Announces Janssen Receives US FDA IND Clearance for VAC85135, an 'Off-The-Shelf' Cancer Immunotherapy Developed using Nouscom's Proprietary Viral Vector Platform | Pharmtech Focus

Nouscom Announces Janssen Receives US FDA IND Clearance for VAC85135, an ‘Off-The-Shelf’ Cancer Immunotherapy Developed using Nouscom’s Proprietary Viral Vector Platform